Skip to main content

Diabetes complications and comorbidities: Ketoacidosis

Journal articles and book chapters

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

06-24-2018 | Drug-induced diabetes | Article

Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors

Stamatouli AM et al. Diabetes 2018. doi: 10.2337/dbi18-0002

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

06-16-2018 | Risk factors | Review | Article

Methods for measuring risk for type 2 diabetes in youth: The oral glucose tolerance test (OGTT)

Chen ME, Aguirre RS, Hannon TS. Curr Diab Rep 2018; 18: 51. doi: 10.1007/s11892-018-1023-3

06-13-2018 | Mental health | Article

Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting

Castellano-Guerrero AM et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1172-5

06-13-2018 | Neonatal diabetes | Review | Article

Congenital diabetes: Comprehensive genetic testing allows for improved diagnosis and treatment of diabetes and other associated features

Letourneau LR, Greeley SAW. Curr Diab Rep 2018; 18: 46. doi: 10.1007/s11892-018-1016-2

05-25-2018 | Diabetes self-management | Article

Type 1 diabetes self-management from emerging adulthood through older adulthood

McCarthy MM, Grey M. Diabetes Care 2018. doi: 10.2337/dc17-2597

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

05-08-2018 | Type 2 diabetes | Review | Article

Type 2 diabetes in youth: New lessons from the SEARCH study

Jensen ET, Dabelea D. Curr Diab Rep 2018; 18: 36. doi: 10.1007/s11892-018-0997-1

04-28-2018 | Heart failure | Review | Article

SGLT2 inhibition and heart failure: Current concepts

Custodio JS et al. Heart Fail Rev 2018; 23: 409–418. doi: 10.1007/s10741-018-9703-2

04-18-2018 | Artificial pancreas systems | Article

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis

Bekiari E et al. BMJ 2018; 361: k1310. doi: 10.1136/bmj.k1310 

04-16-2018 | Type 1 diabetes | Review | Article

The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus

Fattah H, Vallon, V. Drugs 2018; 78: 717–726. doi: 10.1007/s40265-018-0901-y